Latest News
Keep up to date with all our latest investments, service offerings and news items.
Click here to view our latest media kit
-
February 23, 2021 -
January 27, 2021 Almac Group Launches Scholarship Fund, Will Award $50,000 to Triangle Student in 2021
-
January 26, 2021 Almac Group Further Expands Global Biologics Testing Solutions
-
January 25, 2021 The College of Paramedics Opens Dr John Hinds Scholarship Call for Entries
-
January 18, 2021 Professor Daniel Longley Joins Almac Discovery to Accelerate Colorectal Cancer Research
-
January 12, 2021 Almac Group Awarded £Multimillion R&D Grant to Accelerate Enzyme Discovery Unique INSIGHT™ project builds on Almac’s existing enzyme expertise
-
January 11, 2021 Personal Genome Diagnostics and Almac Diagnostic Services Enter Strategic Collaboration to Enhance Patient Care in Oncology
-
December 21, 2020 Almac Group Raises £30k for Southern Area Hospice
-
December 10, 2020 Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery
-
November 17, 2020 Almac Group Works to enable efficient manufacturing of remdesivir in Response to COVID-19
-
November 10, 2020 Almac Group Welcomes COVID-19 Vaccine Trial News Announced by Pfizer & BioNTech
-
November 4, 2020 Almac Group Continues HLA Scheme for Aspiring Scientists, Technologists and Engineers
-
October 14, 2020 Almac Sciences Achieves Thought Leadership Milestone
-
October 7, 2020 Almac Group Appoints Vice President of Small Molecule API
-
September 30, 2020 Almac Group Ranked Second in Belfast Telegraph’s “Businesses making the largest contribution to incomes” Table
-
September 29, 2020 Almac McKervey Award Presented for Excellence in Chemistry
-
September 24, 2020 Almac Group Launches Biologics Testing Solutions
-
September 9, 2020 Almac Clinical Technologies Named Leader in Key Industry Report
-
September 9, 2020 CBS This Morning Features Pfizer’s Phase 3 COVID-19 Vaccine Trial
-
September 8, 2020 Arran Chemical Company Continues Unique Industry – Academia Collaboration with Athlone Institute of Technology
-
September 2, 2020 Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19
-
August 20, 2020 Almac Group Moves to Number Five in Ulster Business Top 100 Companies List
-
August 11, 2020 Almac Clinical Services Launches Virtual Auditing Solution for Clients
-
July 22, 2020 Almac Group “CATCH”es a SFI Industry Fellowship
-
July 21, 2020 Almac Group Announces Winners of claraT Grant Programme for Academia
-
June 24, 2020 Almac Group Launches Tempod® 1000 to Improve Clinical Site Temperature Data Management
-
June 18, 2020 Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
-
June 12, 2020 2018-19 Figures Show Almac Group’s Turnover Increased by £85M to £634M
-
June 4, 2020 Almac Group Welcomes Confirmation that Northern Ireland’s Pharmaceutical Industry will Maintain Regulatory Alignment with the EU Post-Brexit
-
June 1, 2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up
-
May 28, 2020 Almac Group Supports Two COVID-19 Clinical Studies in Sub-Saharan Africa
-
May 14, 2020 Almac Discovery Enters Into Licensing Agreement for the Development & Commercialisation of ALM301
-
May 5, 2020 InMed and Almac Group Developing Improved Cannabinoid Production Methods
-
April 29, 2020 Almac Discovery to Collaborate with MSD on selected DUB therapeutic targets
-
April 24, 2020 TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assay Additions
-
April 22, 2020 Almac Group Achieves Zero Landfill Target
-
April 7, 2020 Almac Clinical Technologies announces expedited support for COVID-19 Clinical Trials
-
March 31, 2020 Self-administered pain-killer saves patient time and NHS resources in accident and emergency departments
-
March 5, 2020 Debiopharm Advances its Potent Wee1 Inhibitor into Clinical Phase
-
March 3, 2020 Call for entries for the Dr John Hinds Scholarship
-
February 18, 2020 Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection
-
February 12, 2020 Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK
-
February 6, 2020 Almac Group launches enhanced Label Approval Solution (LAS)
-
January 28, 2020 Almac Group to Host West Coast Lunch and Learn Workshop Series on Adaptable Clinical Supply Chain Strategies for Biologics
-
January 22, 2020 Almac and Pfizer celebrate success of patient-led clinical supply model in gene therapy trial
-
January 10, 2020 Northern Ireland’s STEM Excellence Celebrated
-
January 8, 2020 Galen, an Almac Company, announces Completion of Multi-Million Pound POA Pharma Acquisition
-
December 12, 2019 Almac Group and Exostar Collaborate to offer Better IRT Experience
-
December 6, 2019 Almac Group’s Comprehensive STEM Programme Wins “Innovation in Sponsorship” Award
-
November 1, 2019 Almac Group Hosts Internationally Recognised Chemistry Forum in Belfast
-
October 21, 2019 Almac Group £35 million Brexit Solution Complete
-
October 7, 2019 Almac Group Hosts Montgomery County Students for National Manufacturing Day 2019
-
October 1, 2019 Almac Group Appoints Dr Alan Lamont as VP BD & Licensing
-
September 26, 2019 Almac’s unique gene expression report enables cancer researchers to discover exciting new insights
-
September 25, 2019 Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone
-
September 17, 2019 Almac Group Participates in Global Clinical Supply BlockChain Working Group
-
September 16, 2019 Almac Group Invests in Future Employees through Apprenticeship Schemes
-
September 3, 2019 Prestigious New Award Announced for Top GCSE Student
-
August 13, 2019 Almac Group to Host Clinical Trial Supply Workshop in Germany
-
August 8, 2019 Almac Group’s Position Remains Unchallenged in Ulster Business Top 100 Listings
-
August 5, 2019 Almac Group to Host EU Product Launch Workshop Series in California and Washington States
-
July 31, 2019 Almac Group Invites Biopharma Industry Members to Learn About Almac Adapt™ – Just in Time Manufacturing at Complimentary Workshop
-
July 31, 2019 Almac Diagnostic Services Launches Sample Management Service
-
July 31, 2019 Almac Diagnostic Services receives CIR (French Research Tax Credit) Accreditation
-
July 26, 2019 Almac Group Promotes High Flying STEM Careers at Airwaves Portrush
-
July 8, 2019 Arran Chemical Company forms Unique Industry – Academia Collaboration with Athlone Institute of Technology
-
July 2, 2019 Almac McKervey Award Presented for Excellence in Chemistry
-
June 13, 2019 Almac Group Launches Almac Adapt™ – a New Patient-centric Supply Solution
-
June 5, 2019 Almac Group Announces CE Mark of Diagnostic Assay to Support Turning Point Therapeutics’ Pivotal TRIDENT-1 Clinical Trial
-
June 3, 2019 Almac Group Reports Further Growth During Period of Significant Global Expansion
-
May 29, 2019 Queen’s researchers work to improve maternal health in the developing world
-
May 28, 2019 Almac Group appoints Dr Sheryl Foster as Vice President of Quality
-
May 6, 2019 Turning Point Therapeutics and Almac Diagnostic Services announce approval of an investigational device exemption for the companion diagnostic assay to the registrational TRIDENT-1 clinical study
-
April 25, 2019 Almac Group Launches TempEZ™ Site Storage Temperature Compliance Module
-
April 18, 2019 Almac Group Partner with Queen’s Researchers to pioneer potentially life-changing oesophageal cancer test
-
April 15, 2019 Almac Group Further Expands Global Analytical Services Capability
-
April 8, 2019 Almac Group Publishes Comparison Report on Automated vs Paper based Accountability & Reconciliation
-
March 27, 2019 Almac Group Launches Upgraded Version of claraT – A Unique, Software-driven Gene Expression Report
-
March 26, 2019 Almac Group Recognised with Six Life Science Leader CMO Awards
-
March 20, 2019 Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting
-
March 18, 2019 Almac Discovery Showcases its Deubiquitinase Drug Discovery Expertise at the American Association of Cancer Research Annual Meeting in Atlanta
-
March 6, 2019 Almac Group Announces Almac ONE™ – A Unified Clinical Trial Supply Solution
-
February 25, 2019 Almac Group Engages with Science Exchange to Promote US Small Molecule Analytical Services
-
February 20, 2019 Almac Group to host Clinical Trial Supply Lunch and Learn Workshop in San Francisco
-
February 18, 2019 Inspiring the Next Generation Almac Group Promotes STEM Careers at W5
-
January 10, 2019 W5 Opens New MED-Lab Exhibition
-
January 8, 2019 Galen Appoints Dr Dennise Broderick as Managing Director
-
January 8, 2019 Almac Group Flows into Continuous Technology
-
January 7, 2019 Stunning Science Success Celebrated
-
January 2, 2019 Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing
-
December 14, 2018 Almac Group Invites Attendees to Join Workshop in San Diego to Learn About Cold Chain Management in Clinical Trials
-
November 7, 2018 Almac Clinical Services Wins Excellence Awards at 2018 Cold Chain Global Forum
-
October 25, 2018 Inaugural Almac McKervey Award Presented for Excellence in Chemistry
-
October 25, 2018 Almac Group Receives Board of Trade Award by the United Kingdom’s Department of International Trade (DIT)
-
October 24, 2018 Almac Group Scoops Research & Development Achievement at 2018 Irish Pharma Industry Awards
-
October 24, 2018 TP Therapeutics and Almac Diagnostic Services Enter into Agreement to Develop Next-Generation Sequencing, Pan-Cancer Companion Diagnostic
-
October 22, 2018 Almac Group Announces Successful HSA Inspection of Singapore Facility
-
October 19, 2018 Almac Group Launches claraT – A Unique, Software-driven Gene Expression Report
-
October 11, 2018 Almac Group Invests in Cutting Edge Next Generation Sequencing Capabilities for Bio Pharma Clients
-
October 10, 2018 Almac Group Invests to Expand its Existing North Carolina Facility
-
October 8, 2018 Search Launched for Local Science Stars
-
October 2, 2018 Almac Group Announces Successful HPRA Inspection at its European Campus
-
October 1, 2018 Almac Group Launches Global Analytical Services Capability
-
September 10, 2018 Almac Group to host Clinical Trial Supply Lunch and Learn at North American Headquarters
-
September 6, 2018 Almac Group Marks 50 Successful Years in Craigavon
-
August 27, 2018 Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK
-
August 21, 2018 Almac Group Appoints Jonothan Cooil as Vice President of Engineering, Facilities and Health, Safety & Environment
-
August 15, 2018 Almac Group Soars up Ulster Business Top 100 Charts
-
August 6, 2018 VNAR Based Oncology Platform in development
-
July 27, 2018 Almac Group Launches GMP High Throughput Peptide Manufacturing Service
-
July 25, 2018 Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
-
July 25, 2018 Almac Group Appoints Three Vice Presidents
-
July 16, 2018 Almac Group Invests in NMR Equipment to Enhance Existing Analytical Services Capability
-
July 6, 2018 “Portadown Gets Active” A summer scheme to support local children and end holiday hunger
-
July 5, 2018 Dr. Xavier Jacq Appointed Vice President, Biology
-
June 5, 2018 Brexit – a seamless solution
-
June 4, 2018 Almac Group turnover surpasses £500 million for first time
-
May 29, 2018 Almac Group’s Vice President of Global Business Development Appointed to British American Business Council of Greater Philadelphia (BABCPHL) Board of Directors
-
May 4, 2018 Almac Group Participates in National Take Our Daughters and Sons to Work Day
-
May 1, 2018 Almac Group Appoints David Taylor as Head of Manufacturing Operations
-
April 27, 2018 Almac Group leads key workshops at the upcoming Global Clinical Supplies Group Conference (GCSG) in Atlanta, GA
-
April 23, 2018 Latest developments in DUB inhibitors shared at Proteasome & Autophagy Congress
-
April 20, 2018 Almac Group Receives Recognition at The Irish Laboratory Awards with Laboratory Supplier of the Year Award
-
April 18, 2018 Almac Group Continues to Share Expertise as part of North America “Lunch & Learn” Seminar Series
-
April 16, 2018 Almac Group Expands US Specialised Commercial Packaging Capabilities
-
April 16, 2018 Almac Diagnostic Services Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials
-
April 10, 2018 Almac Discovery to Present at AACR 2018
-
April 6, 2018 “Portadown Gets Active” — A scheme to support local children and end holiday hunger
-
March 26, 2018 Almac Group named by Deloitte as One of Ireland’s Best Managed Companies
-
March 22, 2018 Almac Group Recognised with CMO Leadership Awards
-
March 22, 2018 Almac Group Launches ‘Almac McKervey Award’ for Excellence in Organic Chemistry
-
March 20, 2018 Almac Group Partners with Indian Valley Chamber of Commerce
-
March 12, 2018 Almac Group Presents “Sir Allen McClay Award for Excellence in Chemistry”
-
March 8, 2018 US East coast storm: update
-
March 2, 2018 Storm Emma – Update
-
February 28, 2018 Almac Group Expands with Opening of £20 million Cold Chain Facility
-
February 12, 2018 Almac Diagnostic Services Partners with DNAnexus to Power Clinical Trial Assay Development
-
January 29, 2018 Research Highlighted in Nature Chemical Biology
-
January 29, 2018 Almac Group Appoints Dr Stefan Mix as Head of Biocatalysis
-
January 24, 2018 Almac Group Launches Bespoke Elemental Impurities Laboratory
-
January 23, 2018 Almac Group Implements Salesforce Service Cloud to Enhance Client and Clinical Site User Experience
-
January 18, 2018 Almac Group announces further expansion at its European Campus in Dundalk
-
January 5, 2018 Stunning Science Success Celebrated
-
January 2, 2018 Almac Group Launches Second Line for High Throughput GMP Peptide Manufacturing
-
December 8, 2017 Young people presented with accredited awards at celebration event
-
December 5, 2017 Almac Group Receives Annual Industrial Award from the Institute of Chemistry of Ireland
-
December 4, 2017 USP7 inhibitors from UbiPlexTM Platform published
-
November 13, 2017 Almac Clinical Technologies’ President & Managing Director Keynotes Life Sciences PA’s CRO & CMO Summit
-
November 6, 2017 Almac Group Enters Strategic Partnership with W5
-
November 2, 2017 Almac Group’s US Financial Controller Appointed to Irish American Business Chamber & Network (IABCN)’s Board of Directors
-
November 1, 2017 Veeva Systems Inc.: Veeva Announces Partner Approach for Best-in-Class Randomization and Trial Supply Management
-
November 1, 2017 Almac Group Announces Acquisition of BioClin Laboratories
-
October 24, 2017 Almac Group Introduces Accountability and Reconciliation Tracking
-
October 23, 2017 Queen’s University Belfast in Collaboration with Almac Group Lead Largest Study of its Kind to Transform Prostate Cancer Treatment
-
October 23, 2017 Almac Group Announces Successful MHRA Inspection at Charnwood Facilities
-
October 18, 2017 The Search is on for ‘Northern Ireland’s Top Science Students
-
October 16, 2017 Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions
-
October 16, 2017 Hurricane Ophelia: Almac Group Update
-
October 6, 2017 Almac Group Wins Export Achievement Award at the Pharma Industry Awards
-
September 13, 2017 Almac Group Leads Economic Growth in Pennsylvania and the U.S.
-
September 4, 2017 ALM201 Poster Presentation at 2017 ESMO Congress
-
August 10, 2017 Almac Group Announces US Workshops Targeting EU Product Launch Best Practices
-
August 10, 2017 “Portadown Gets Active” A scheme to support local children and end holiday hunger
-
August 7, 2017 High-demand IT skills being developed at innovative summer camp
-
July 3, 2017 ALM201 – Orphan Drug Designation Granted in Ovarian Cancer
-
July 3, 2017 Lismore Comprehensive Represents Northern Ireland in Young Enterprise UK final
-
June 30, 2017 Petya ransomware attack – Almac update
-
June 23, 2017 Almac Group scoops top prize at Made in the UK Awards
-
June 20, 2017 Agreement with Debiopharm to Develop Novel Wee-1 Inhibitor
-
June 19, 2017 Almac Group Recognised as a Top 50 Company for Transatlantic Operations
-
June 13, 2017 Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay
-
June 8, 2017 Almac Group Reports Pre-tax Profits of £27M
-
May 16, 2017 Almac Group Executives Share Expertise at Upcoming Industry Conferences
-
May 8, 2017 Wee-1 kinase patent approval granted
-
April 20, 2017 Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
-
March 15, 2017 Almac to Exclusively Share Global Expertise in EU Product Launch Workshop
-
March 14, 2017 Almac Group Executives Share Expertise at Key Industry Events
-
March 8, 2017 Almac Diagnostic Services and EORTC Establish Collaboration for Tumour Molecular Profiling
-
February 28, 2017 Irish Ambassador to US will present distinguished awards to Beneficial Bank, Eileen McDonnell, and Sean Rooney
-
February 22, 2017 Almac Group Hosts Official Visit by British Deputy Consul General
-
February 16, 2017 Almac Diagnostic Services Appoints Dr Leeona Galligan as Vice President UK Operations
-
February 14, 2017 Therapy-resistant cancer tumours targeted with RCSI
-
January 30, 2017 Almac Group Launches Next Generation Temperature Management Software
-
January 26, 2017 Almac Group Announces Further Global Expansion as it Secures New Premises in Republic of Ireland
-
January 12, 2017 Almac Group Executive to Speak at IQPC Clinical Trial Supply Europe 2017
-
January 9, 2017 Almac Group Launches Almac Clinical University
-
December 15, 2016 Almac Group Collaborates with Exostar to Extend Clinical Trials Identity Management
-
December 13, 2016 Almac Group Appoints Professor Tom Moody as VP of Technology Development and Commercialisation
-
December 12, 2016 Almac Group Trio are Masters of Work and Study
-
December 6, 2016 Almac Group Announces Strategic Partnership with inVentiv Health
-
November 28, 2016 Almac Group Executive to Speak at CTS East Asia Conference
-
November 17, 2016 Almac Group Team Up with Irish American Business Chamber & Network for Life Sciences Forum
-
November 14, 2016 Almac Group Expands Commercial Capabilities to Meet Industry Demand for Paediatric Formulations
-
November 10, 2016 Almac Group Announce £27 million Global Expansion
-
October 28, 2016 Almac Group Appoints Dr. Victor Diaz Perez as Head of Physical Sciences
-
October 18, 2016 Almac Group’s Temperature Management Software Solution Receives Innovation Award
-
October 14, 2016 Almac Group Wins Prestigious Research and Development Award
-
October 10, 2016 Almac Group Discover an Exciting Link between its Immune Response Assay and Checkpoint Inhibitor Based Therapy
-
October 4, 2016 Almac Diagnostic Services Partner with ArcherDX
-
September 20, 2016 Almac Group Celebrates 20 Years in North America with $5.2 million Expansion Creation of 79 Additional Jobs in North Carolina
-
August 8, 2016 Almac Publish Second Validation of Stage II Colon Cancer Recurrence Assay in the Journal of Clinical Oncology
-
August 2, 2016 Almac Group’s Integrated Development to Commercialisation Services Support Amicus Therapeutics’ First Commercial Orphan Drug Product
-
July 14, 2016 Almac Group’s Rapid Launch Services Support U.S. Approval of Intercept Pharmaceutical’s First Commercial Orphan Drug Product
-
June 14, 2016 Successful Inspection by FDA of Almac Clinical Services North Carolina Facility
-
June 8, 2016 Almac Diagnostic Services Expand Companion Diagnostic Development Service Offering with NanoString Barcoding Technology
-
June 2, 2016 Almac Appoints New Vice President of Corporate Marketing
-
May 30, 2016 Diseases of the eye explored with McClay Foundation and UU
-
May 23, 2016 Almac to partner with ZYMtronix to deploy its universal enzyme immobilisation platform
-
May 9, 2016 The Almac Pod™ – Changing the Dynamics of Temperature Controlled Shipping Solutions
-
April 25, 2016 Almac Clinical Technologies Announces Participation in the Avoca Diligent Prequalification Platform
-
April 25, 2016 Almac Group Launches US Serialisation Solution in Partnership with Optel Vision
-
March 23, 2016 Almac Wins Three CMO Leadership Awards
-
March 8, 2016 Almac Group Opens Additional Companion Diagnostic Laboratory in Durham NC USA
-
March 2, 2016 Almac Group Win Irish American Business Chamber Award in USA
-
January 25, 2016 NEW Fluorescence Lifetime Platform Unveiled at SLAS
-
November 12, 2015 Almac Group to Collaborate with Illumina on Next-Generation Sequencing Based Companion Diagnostic Development
-
November 9, 2015 Almac Group announces significant expansion in pharmaceutical development capacity
-
November 3, 2015 Almac Acquires Arran Chemical Company and Expands Biocatalysis Services
-
October 12, 2015 Industry’s Newest Generation IRT Fuels Growth of Almac Group’s Business
-
October 7, 2015 Almac Group Addresses Industry Demand for Multiparticulate Drug Products with Scalable Fluid Bed and Encapsulation Technologies
-
October 5, 2015 European Patent Protection for ALM201 Secured
-
September 9, 2015 Almac Group’s Integrated CMC Services Support US Approval of Wellstat Therapeutics’ First Commercial Orphan Drug Product
-
September 7, 2015 Almac Group’s Asia Pacific Headquarters Receives Official Health Science Authority (HSA) Accreditation
-
September 7, 2015 Almac Group Expands Clinical Trial ‘Direct to Patient’ Service throughout Europe
-
July 10, 2015 Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore
-
July 10, 2015 Almac Group Appoints New Vice President of Global Business Development
-
July 10, 2015 Almac Group Appoints Dr. John Robson as VP Quality Operations
-
July 10, 2015 Almac Group Announce Companion Diagnostic Partnerships with OncoMed
-
July 10, 2015 Ubiquitin Specific Protease Collaboration with Genentech
-
July 10, 2015 Almac Group Named UK Trade & Investment Winner in Final of the European Business Awards 2014/5
-
March 3, 2015 Almac Group Appoints Dr. Shirin Khambata Ford as VP Product Development
-
February 5, 2015 Almac Group Drives Biocatalysis Leadership with a Further $7M Investment
-
February 5, 2015 Almac Appoints VP Quality and Regulatory Affairs
-
December 8, 2014 Almac Crowned overall Ulster Bank Business Achiever
-
November 26, 2014 Almac raises £9,000 for ovarian cancer charity in memory of employee
-
November 5, 2014 Almac continues winning streak at Irish Pharma Industry Awards 2014
-
October 21, 2014 Almac’s PATHWAY™ Points Students in Right Direction for STEM Careers
-
October 20, 2014 Almac Introduce Flexible Clinical Trial Direct to Patient Solution
-
July 10, 2014 PA Governor Tom Corbett Praises Almac during Visit
-
June 5, 2014 Almac Launches Recruitment Drive to Fill up to 20 New Positions
-
June 2, 2014 Almac validates novel test for Ovarian Cancer patients
-
May 27, 2014 Almac sees profits increase by 30% as company enjoys record year
-
May 1, 2014 Almac flies high at Aer Lingus Viscount Awards
-
March 28, 2014 Almac Achieves Double Success at Business Award Ceremony
-
March 11, 2014 Almac Expands Asia Pacific Operations, Establishes Regional Operations Center in Singapore
-
January 28, 2014 Data Presented Supporting Almac Developed Colon Signature as a Significant Predictor of Risk of Recurrence in Stage II Colon Cancer
-
January 21, 2014 Almac publishes breast cancer chemotherapy response assay in the Journal of the National Cancer Institute
-
December 10, 2013 Almac wins Laboratory Team of the Year at The Irish Laboratory Awards 2013
-
November 26, 2013 Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
-
November 18, 2013 Almac Further Enhance 3rd Party Logistics Commercial Support Services for Niche / Orphan Drugs
-
November 13, 2013 Almac’s Strengthened Facilities Accommodates Demand of Late Stage API Manufacture
-
November 5, 2013 Almac Increase Global Stability Storage Capacity
-
October 29, 2013 Richard Segiel, Jr. Joins Almac as Vice President of US Business Development
-
October 23, 2013 Almac invests to accelerate formulation development services
-
October 22, 2013 Almac expands US & UK commercial facilities
-
October 22, 2013 Novozymes Biopharma announces collaboration with Almac in Drug Manufacture, Half Life Extension and Targeting Technologies
-
October 7, 2013 Almac Launches New [14C]-labelled ADCs Service Offering
-
September 23, 2013 Almac Launches SupplyTraQ™ Technology Solution to Streamline Clinical Trial Supply Administration
-
September 19, 2013 Almac Launches Reusable Shipper Option for Temperature-Controlled Distribution
-
September 10, 2013 Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service
-
September 4, 2013 £13m Investment Cancer Research Initiatives with QUB
-
July 31, 2013 Almac Receives Appreciation Award from Otsuka America Pharmaceutical, Inc.
-
July 2, 2013 Almac Introduce Contained Drug Handling and Bottling Capabilities in EU and US Clinical Services Sites
-
June 11, 2013 ALMAC ANNOUNCES FURTHER EXPANSION AND 229 NEW JOBS
-
June 7, 2013 Almac Employees Reward Macmillan Belfast, Mindwise Lurgan and Craigavon’s Neonatal Unit in Annual Charity of Choice Survey
-
May 15, 2013 Almac secures new metagenomics and enzyme discovery programme with UCL
-
April 26, 2013 You don’t need to wear a lab coat to work at Almac!
-
February 20, 2013 Almac Receives FDA Inspection Approval
-
February 18, 2013 Almac and DSM Collaboration Agreement in Biocatalysis Continues with Success
-
February 13, 2013 Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event
-
February 6, 2013 Almac launches US commercial packaging operations with successful FDA inspection and new client partnership
-
January 21, 2013 Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade
-
January 14, 2013 Almac Doubles Drug Product Development Capacity with a New Non-GMP Facility
-
January 7, 2013 Almac and TTP Labtech form alliance in fluorescence lifetime technology
-
December 12, 2012 Charlie Morris Appointed to Almac’s Clinical Technologies Executive Team
-
November 16, 2012 Almac’s Early Christmas Present to Local Cancer Charity
-
November 7, 2012 Recycling works: Almac’s new environment initiative saves £72,000 per year
-
October 10, 2012 Almac increase early phase ‘hit to lead’ chances with Pre-Clinical Screening Packages
-
October 9, 2012 Almac Concludes Commercial API Manufacturing Facility Expansion Plans
-
October 8, 2012 Almac and DSM Sign Collaboration Agreement in Biocatalysis
-
October 3, 2012 Almac expands UK commercial capacity with the acquisition of new blistering technology
-
September 26, 2012 Successful MHRA Inspection of Almac’s Clinical Services UK Facility
-
September 17, 2012 Almac Launches New Histone Reagents Catalogue and Custom Synthesis Service
-
August 21, 2012 Almac announces launch of Next Generation Sequencing service for personalised medicine
-
August 8, 2012 Almac Streamline Temperature Sensitive Clinical Supplies with Enhanced Service Offering
-
July 18, 2012 US Consul General applauds Almac’s economic contribution to the US pharmaceuticals market
-
July 2, 2012 Almac launches mobile website in response to large mobile user base
-
June 13, 2012 Almac Introduces Qualified Person Facilitation Program
-
June 11, 2012 Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products
-
May 14, 2012 Almac Adds High-Speed Clinical Trial Blistering Equipment at US HQ
-
May 1, 2012 Almac installs Uhlmann Blister Line in new US Commercial Packaging Facility
-
April 26, 2012 Almac Rewarded for Excellence in Technology
-
April 4, 2012 Almac reports progress in Clinical Technologies Lean Six Sigma Efforts
-
March 29, 2012 Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array
-
March 15, 2012 Almac’s Clinical Trial Workshop Series to return in 2012
-
March 15, 2012 Almac and SRC to boost training for science careers
-
March 12, 2012 Almac adds aXcess™ to its suite of services to complement clinical packaging and distribution bundle
-
March 7, 2012 Almac expands in US with addition of Commercial Packaging facility in Audubon
-
February 28, 2012 Almac Boosts Capacity and Productivity with Acquisition of New Encapsulation Equipment
-
February 13, 2012 selectAZyme™ grows into metabolite synthesis
-
February 9, 2012 One Year On…Almac Doubles Analytical Capacity in US Headquarters
-
February 1, 2012 Almac announce launch of Next Generation Sequencing (NGS) Data Analysis Services
-
January 23, 2012 Almac Celebrates MHRA Audit Successes
-
January 17, 2012 MGB Biopharma and Almac Collaborate on Contract Manufacturing Project
-
January 11, 2012 Almac strengthens Board with appointment of new Financial Director
-
January 9, 2012 New building will help Almac serve customers from Argentina to Zimbabwe
-
November 30, 2011 Almac’s Diagnostic Laboratory Receives Accreditation from College of American Pathologists
-
November 29, 2011 Almac extends helping hand to local charities
-
November 28, 2011 Almac Shines At Awards Ceremonies
-
November 21, 2011 Almac Responds to Alexion’s Request for Rapid Packaging and Distribution During Public Health Crisis in Germany
-
November 17, 2011 Co Tyrone woman is Almac’s 2,000th UK employee
-
November 8, 2011 Almac publishes Stage II colon cancer recurrence signature in the Journal of Clinical Oncology
-
October 25, 2011 Almac’s rapidd continuing to accelerate early stage development 2 years on
-
October 24, 2011 Almac Invests in New Commercial API Manufacturing
-
October 21, 2011 Almac Invests £1M in Dedicated Mass Spectrometry Laboratory
-
October 20, 2011 Almac Announces Expansion of Pharmaceutical Development Facilities
-
October 5, 2011 Almac and Greenphire Form Alliance to Deliver Direct-to-Patient Stipend Payments Through IXRS®
-
September 23, 2011 Almac flies the flag for European Day of Languages
-
September 8, 2011 Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion
-
September 7, 2011 Almac-Queen’s cancer expert to lead £4.4m collaboration
-
July 19, 2011 Almac wins ‘The American Society for Quality’ Award in Philadelphia
-
July 4, 2011 Almac to perform the analytic phase of AclarusDx™ for Exonhit
-
June 30, 2011 Almac Expands Global Coverage by Adding Depots for Clinical Trial Supply Distribution to the Asia Pacific Region
-
June 17, 2011 Almac to Feature New Enhancements to its Integrated Supply Chain Management and Patient Compliance Services at the Annual DIA Meeting in Chicago
-
May 31, 2011 Almac data to be presented at annual ASCO meeting
-
May 20, 2011 Almac celebrate official opening of North American HQ with former US. Senator George Mitchell
-
May 11, 2011 Almac to host inaugural European Product Launch workshop for US Biopharmaceutical Companies
-
May 6, 2011 Todd Kole Appointed to Almac’s Clinical Technologies Executive Team
-
May 4, 2011 Almac Introduces selectAZymeTM
-
April 13, 2011 Almac wins 2011 Northern Ireland Business of the year accolade
-
April 7, 2011 Northgate Managed Services Delivers Seamless Transfer to Almac’s New US HQ
-
March 30, 2011 Almac open CLIA lab for biomarker clinical trials
-
March 28, 2011 BioFocus and Almac collaborate to offer fluorescent lifetime assays
-
March 25, 2011 Almac announces expansion to its commercial facility with the addition of increased storage capacity for biologic products
-
March 23, 2011 Almac to Demonstrate New Patient Management Services at the Euro DIA and Partnerships in Clinical Trials Conferences
-
March 16, 2011 The A to ZED of Automated Walleting for clinical trial supply
-
March 1, 2011 Live Webinar March 28th: An Integrated Approach to Biomarker Discovery
-
February 28, 2011 Almacs New Headquarters Takes Control of Scheduled I-V Substances Capabilities
-
February 17, 2011 Almac announce Launch of Bioinformatics Consultancy
-
February 14, 2011 Graham Nicholls of Almac Group to Speak on Adaptive Trial Designs and Clinical Supplies at CTS Europe Conference
-
February 7, 2011 Almac Opens Analytical Labs in New US Headquarters
-
January 19, 2011 Distribution Heats Up as Almac Continues its Transition to New North American Headquarters
-
December 16, 2010 Almac wins News Flow of the Year Category at the Genesis 2010 Awards
-
November 26, 2010 Almac adds Late Stage Customisation Suite to assist Orphan Drug / Niche Product Launches into Europe
-
November 23, 2010 Almac discusses its investment in biocatalysis lauding cost and environmental benefits on OutsourcingPharma.com
-
November 19, 2010 Almac and the Royal Society of Chemistry host a workshop on the use of analytical techniques to control and monitor solid form
-
November 10, 2010 Almacs Clinical Technologies Business Unit Again Receives `Best Places to Work in PA 2010′ Award
-
October 18, 2010 Almac has Successful MHRA Inspection at its Clinical Services UK Site
-
October 13, 2010 Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters
-
October 7, 2010 Almac continues biocatalysis business growth with a further $4m R&D investment
-
October 4, 2010 Almac ‘Event in the Tent’ raises £14,500 for Charities
-
October 4, 2010 Almacs North American Headquarters Opens Its Doors for Audits
-
September 21, 2010 Almacs Clinical Technologies Division undergoes successful joint GCP-GMP MHRA Inspection
-
September 20, 2010 Almac One Step Closer to Completion of U.S. Headquarters Buildings
-
September 3, 2010 View our Client Message Regarding New North American Headquarters
-
August 26, 2010 Almac Discusses New Biomarker Service on OutsourcingPharma.com
-
August 2, 2010 Almac launch Biomarkers for biopharma
-
July 9, 2010 Bill Kane Joins Almac as Director of Quality Assurance and Regulatory Compliance
-
July 7, 2010 Almac supports Queens University “oncology hub” with new McClay library
-
June 28, 2010 Almac Announces Collaboration with Aeterna Zentaris to Develop Therapy and Companion Diagnostic in Cancer
-
June 23, 2010 Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of Almac
-
June 21, 2010 Almac’s US Headquarters will Address Capacity Demand for Clinical Supplies
-
June 14, 2010 Almac completes £2 million client sponsored investment expanding commercial sacheting capacity
-
June 11, 2010 Almac to feature Expert Speakers at Upcoming DIA Annual Meeting
-
June 9, 2010 Almac Announces Launch of IXRS® 2.0 Next Generation Clinical Technology
-
June 3, 2010 Almac Launch Xcel Array – the Optimum Platform for Biomarker Discovery
-
May 26, 2010 Almac wins UK Great Place to Work award
-
May 12, 2010 Almac and University College Cork announce launch of academic/industrial collaboration
-
May 5, 2010 Almac’s North Carolina Facility Continues Growth in Academically based Clinical Trials
-
April 29, 2010 Almac extends Site-specific PEGylation Technology to single domain antibodies
-
April 22, 2010 Almac Announces Environmentally-Friendly Features
-
April 21, 2010 Graham Nicholls Joins Almac as Director of Biostatistics
-
April 19, 2010 Almac completes its expansion plan to Pharma Services facilities
-
April 15, 2010 Almac Group Finds Pharmony With New Website
-
April 12, 2010 Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy
-
April 8, 2010 Almac Clinical Technologies Releases Almac Interactive Reporting for IXRS
-
April 7, 2010 Almac wins Excellence in Innovation Category at Tenth Annual Belfast Telegraph / BMI Northern Ireland Business Awards – Read more.
-
April 7, 2010 New FLEXYTE® Protease Assays Enable Information-rich Output, Miniaturization and Multiplexing
-
April 1, 2010 Almac to Improve Label Approval Process in Clinical Trials
-
March 17, 2010 Almac and Queens University Belfast showcase Northern Irish ‘oncology hub’ to senior Washington DC delegates
-
March 8, 2010 Almac wins prestigious Aer Lingus Viscount Award for Overall Excellence
-
March 5, 2010 Successful Inspection by FDA of Almac Clinical Services North Carolina Facility
-
February 26, 2010 Almac Expands Radiolabelling Facilities to Include 14C API and IMP Supply
-
February 17, 2010 Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
-
February 10, 2010 Almac adds Xcelodose® 600S Precision Powder Micro-dosing System to its Product Development Capabilities
-
January 18, 2010 Almac Announces that AstraZeneca is to Undertake Evaluation FLEXYTE Protein Kinase Assays
-
January 13, 2010 Statement on the Sad Death of Sir Allen McClay
-
December 7, 2009 Almac Clinical Technologies Announces Patient-Reported-Outcomes Partnership with FACIT.org
-
December 1, 2009 Bioinformatics Expansion Heralds Further Growth for Almac
-
November 16, 2009 Almac Doubles Capacity at North Carolina Facility
-
November 10, 2009 Almac to Speak at Upcoming CDISC Interchange with Technology Partners
-
November 2, 2009 Almac Launches Unique Site-specific PEGylation Technology at BIO Europe
-
October 15, 2009 Almac Announce Potent Containment Capabilities
-
October 14, 2009 Almac Extends Commercial Support Services to add Third Party Logistics “3PL”
-
October 14, 2009 “rapidd” Accelerating Early Stage Development, Minimising Cash Burn
-
October 13, 2009 US Labs will Extend Analytical and Solid State Support
-
October 13, 2009 Almac and Edinburgh Instruments launch of FLEXYTE fluorescence lifetime assays at MipTec
-
October 9, 2009 Almac staff raise £9,000 for local charities
-
October 1, 2009 Almac Clinical Technologies Named One of the ‘Best Places to Work in PA 2009’
-
September 29, 2009 Almac Secures Room to Grow; Plans Expected to Lead to 500 Jobs
-
September 15, 2009 Almac and Lilly Partner on Companion Diagnostic Development
-
September 2, 2009 Establishment of McClay Foundation Marks New Era for Northern Ireland
-
July 28, 2009 UM Breast Cancer Researchers partner with Almac to win prestigious Department of Defense Grant
-
July 21, 2009 MHRA Grants Almac IMP License for its Radiolabelling Service
-
July 15, 2009 Almac Group Continues Aggressive Hiring Campaign in PA to Meet Growing Demand from Pharma and Biotech Customers
-
July 9, 2009 Official opening of Almac Diagnostic Services headquarters
-
June 30, 2009 Almac Completes Phase 1 of its Expansion Plan to Pharma Services Facilities
-
June 17, 2009 Almac to Showcase Integrated Clinical Trial Solutions at 45th Annual DIA Meeting
-
June 2, 2009 Almac and Middlebrook Pharmaceuticals discuss their successful partnership in Tablets and Capsules
-
May 18, 2009 Almac Announces Collaboration with Pfizer and the PETACC3 Translational Research Working Party
-
May 15, 2009 Almac Event Proves Engineers Make It Happen
-
April 29, 2009 Dr Tanney Discusses Challenges Faced in Fine Tuning Sample Preparation Techniques
-
April 27, 2009 Minister Praises Craigavon Life Sciences Firm’s Commitment to R&D
-
April 23, 2009 Almac Launches Biocatalyst Kits
-
April 23, 2009 Almac and PHT Announce Formal Alliance to Improve Clinical Trial Data Quality
-
April 6, 2009 Almac – `Business of the Year Award is Company Milestone’
-
April 6, 2009 Almac Group Uses HP Technology to Bring New Drugs to Market Faster
-
March 19, 2009 Almac Showcases ePRO Technology at 21st DIA EuroMeeting
-
March 18, 2009 Almac Tops Off New North American Headquarters
-
March 10, 2009 Almac Collect Top Recognition for New Ovarian Cancer Research Product
-
March 5, 2009 Almac Win “Exporter of the Year” in Economic Awards
-
February 24, 2009 Almac Completes First Paperless Client Audit
-
February 13, 2009 Almac Continues Global Expansion of Clinical Supply Services with Huge Facility for Specialist Storage
-
February 5, 2009 Almac Jobs Boost for Northern Ireland
-
February 5, 2009 Almac Pharma Services Retained by MiddleBrook Pharmaceuticals to Produce Physician Samples of MOXATAG
-
January 29, 2009 Almac Promotes Biocatalysis and Radiolabeling
-
January 29, 2009 Almac Launches Solid State Services
-
January 26, 2009 Intelligroup Secures Multi-Million Dollar COSMOS Implementation with Almac Clinical Services
-
January 19, 2009 Key Almac division celebrates 20 years of growth
-
January 8, 2009 Almac Selects NuGEN Ovation® Systems to Broaden Gene Expression
-
January 7, 2009 Almac Clinical Technologies Expands Yardley, PA Headquarters
-
January 6, 2009 Almac Growth Continues Into 2009
-
December 1, 2008 Almac Clinical Services milestone achievement as full GMP compliance achieved across global sites
-
November 27, 2008 Almac addresses leading cancer specialists at All-Ireland conference
-
October 10, 2008 Almac Clinical Services Craigavon Facility Achieves Successful Inspection by MHRA
-
October 8, 2008 Almac Group Staff Raise £7,000 for Local Charities
-
September 29, 2008 Successful inspection by MHRA of Almac Clinical Services’ Pennsylvanian facility
-
September 18, 2008 “Real potential of clinical technologies yet to be realized” says Almac
-
September 16, 2008 Almac Diagnostic Services Launches Ovarian Cancer Research Tool
-
August 11, 2008 Almac Donate $50,000 to Harleysville Area Emergency Medical Services
-
July 31, 2008 Almac Announce World’s Largest Gene Expression Study To Develop Prognostic Test for Early Non Small Cell Lung Cancer
-
July 24, 2008 Governor Rendell and Sir Allen McClay break ground at site of new Almac North American headquarters
-
July 2, 2008 Almac Testers Receive ISTQB Software Testing Certification
-
June 27, 2008 Almac Diagnostic Services Join Personalized Medicine Coalition
-
June 10, 2008 Almac Group Launches Oncology Discovery Arm
-
May 20, 2008 Almac Clinical Technologies signs contracts for a number of large, complex Clinical Trials
-
May 12, 2008 WebEZ™ reaches a key milestone
-
May 8, 2008 Almac Diagnostic Services in new deal to provide unique process to extract genetic information from Clinical Trial samples
-
March 31, 2008 Almac Showcases Fully Integrated Suite of e-technologies at Partnerships with CROs and EDC & Beyond
-
March 20, 2008 Almac Pharma Services Expands it Commercial Support Capability
-
March 17, 2008 Almac appoints new VP Commercial Operations for Pharma Services
-
February 26, 2008 Almac Inks 15-Year Deal with Affy to Secure Rights to Develop and Sell Array-Based Dxs
-
February 23, 2008 The Power of Communication
-
February 21, 2008 Almac Diagnostic Services Extends Agreement with Affymetrix
-
February 19, 2008 Almac Expands Express Suite at DIA EuroMeeting
-
January 29, 2008 Largest Ever Clinical Trials Cargo Shipped from Northern Ireland
-
January 28, 2008 Almac: more US connections
-
January 11, 2008 Almac & Merck to Present Adaptive Case Study at Upcoming Conference
-
December 18, 2007 Almac wins top award at Tech Idol Showcase
-
December 5, 2007 Almac Sciences: a global supply chain approach
-
December 5, 2007 Almac Sciences: “First in man” approach to peptides
-
November 23, 2007 Almac at the center of industry thinking
-
November 20, 2007 BRCA1 Mutations Influence Cancer Cells’ Response to Drugs
-
October 23, 2007 Almac to Build New US American Headquarters
-
October 16, 2007 Almac Teams up with the Leukemia and Lymphoma Society
-
October 15, 2007 Northern Ireland First Minister Commends Almac as a World Class Pharmaceutical Organisation
-
October 8, 2007 Almac Clinical Technologies Hires New Director in San Francisco Office
-
September 11, 2007 Recent Survey Results Praise Customer Service
-
August 28, 2007 Almac’s Web Drug Reconciliation tool named finalist in GCPj awards
-
August 8, 2007 Top of the Class for Almac Fundraisers
-
August 8, 2007 Almac Diagnostic Services Announces Pioneering Genetic Research on Ductal Carcinoma In Situ (DCIS) Using Breast Cancer DSA™ Research Tool
-
August 6, 2007 Sir Allen Interview Features in Belfast Telegraph’s “The Monday Interview”
-
July 31, 2007 Almac Clinical Technologies Launches IXR Express: A new way for clients to accelerate the clinical trial process
-
July 25, 2007 Almac present on Investigational Medicinal Products to leading Industry body
-
July 3, 2007 Almac Clinical Services Feature in “The Big Question”
-
June 25, 2007 Almac Group Highly Commended at NI Workplace and Employment Awards
-
June 20, 2007 Almac Clinical Services to present at FDA Symposium at Harvard University.
-
May 31, 2007 Almac Diagnostic Services Attends Pre-ide Meeting With FDA for Colorectal Cancer Diagnostic Derived from FFPE Tissue Craigavon, Northern Ireland, 28 May 2007
-
May 31, 2007 Prof Patrick Johnston of Queen’s University Belfast & Almac Diagnostic Services honoured by President McAleese
-
May 23, 2007 Almac Clinical Technologies speaks on ‘Quality’ at 43rd DIA Annual Meeting
-
May 17, 2007 Latest iTrial EDC includes new PDF Audit Trail function
-
April 30, 2007 Almac Launches New Innovative Clinical Supply Systems
-
April 27, 2007 Almac Hosts Successful Clinical Supply Management Workshops across North America
-
April 19, 2007 `Increase Role of Science in Schools’ says Almac Chairman
-
April 16, 2007 Almac Diagnostic Services Announces Pioneering Genetic Research
-
March 16, 2007 Sir Allen McClay: “Almac Leading The Way In Global Pharmaceutical Development”
-
March 9, 2007 Almac Sciences Feature in “What Job Do You Do?”
-
March 9, 2007 Almac Clinical Technologies At Top Clinical Trial Conferences
-
March 8, 2007 Almac Sciences Invest In Edinburgh Facility
-
March 5, 2007 Almac visit QUB to brief Pharmacists
-
February 14, 2007 SafeBridge® Certification for Almac Sciences’ cytotoxics plant
-
February 14, 2007 Almac Sciences and BioCatalytics Inc. to co-operate on key pharma products
-
February 14, 2007 CPST fill-and-finish agreement for Almac Sciences’ cytotoxics
-
January 29, 2007 Almac Clinical Technologies Appoints New Director of Business Development
-
January 22, 2007 Almac distribution network now worldwide
-
December 29, 2006 Almac Recruits Additional 250 Employees in NI in 2006
-
December 20, 2006 Almac Clinical Technologies Spreading Holiday Cheer
-
December 19, 2006 Diagnostic Services Multi Year License Agreement With GeneGo
-
December 18, 2006 Almac Scoops Top UK Training Award
-
December 18, 2006 Clinical Technologies Expands Its European Operations
-
December 5, 2006 Almac Clinical Services Celebrates 10 Years in US
-
November 10, 2006 Almac Pharma Services Extend Formulation Facilities
-
October 26, 2006 Almac Hosts Science Development Day for Colleges
-
October 18, 2006 Almac Clinical Services Scoops National Training Award
-
October 10, 2006 Almac Sciences Scales Up for Peptides
-
September 29, 2006 Almac Staff Raise Funds For Northern Ireland Charities
-
September 5, 2006 Almac Clinical Technologies Celebrates Successful Launch of Drug Reconciliation Tool
-
August 17, 2006 Clinical Services Continues Expansion with New Refrigerated Facility
-
August 10, 2006 Clinical Services Expands Its Global Depot Network
-
June 19, 2006 Pharma Companies Combine Under Almac Banner
-
May 22, 2006 CTS Awarded Best Classroom Training Manual at 2006 PDA Biennial Training Conference
-
May 22, 2006 ICTI Announces New President
-
May 4, 2006 CTS Durham Undergoes EU-GMP Inspection From MHRA
-
April 25, 2006 ICTI to Speak on Adaptive Trial Design at Brussels Conference
-
April 25, 2006 CTS Host Successful Global Clinical Trial Distribution Workshops In The US
-
March 28, 2006 Health Minister Visits Almac Sciences Facility
-
March 27, 2006 ICTI Presents at DIAs 21st Clinical Data Management Symposium
-
March 22, 2006 ICTI Implements Latest Version of MasterControl Training
-
March 21, 2006 Almac Helps Governor Take Temperature Of NI Economy
-
March 20, 2006 World Renown Cancer Specialists Visit Almac Sciences
-
March 20, 2006 PDMS Extend Formulation Development Facility
-
March 9, 2006 Eirx Therapeutic Plc & Diagnostic Services Agreement
-
February 16, 2006 CSS Radio Goes Live; Chiral Building Blocks Range Announced
-
February 13, 2006 Sir Allen McClay Opens New £1.25 million Laboratory of Biology Chemistry at Queens
-
February 3, 2006 CTS Announce Agenda for Clinical Trial Distribution Workshops
-
January 24, 2006 ICTI Biostatistics Expert speaks at International Conference
-
January 11, 2006 Almac Diagnostic Services Receives ISO17025 Accreditation
-
January 10, 2006 ICTI Expands European Operations
-
January 10, 2006 ArraDx Joins Almac Sciences – Now Almac Diagnostic Services
-
January 9, 2006 Dr Allen McClay, CBE Receives Knighthood in New Year’s Honours List
-
December 23, 2005 ICTI Completes Implementation of Tech-Support Software: IncidentMonitor TM
-
November 29, 2005 CSS Focuses on Australian Market
-
November 25, 2005 CSS Launches Global Provision of Radiolabelling Services
-
September 21, 2005 ICTI software used in major Government Study
-
September 14, 2005 ICTI Expert Hosts Roundtable at FDA Conference
-
July 19, 2005 ICTI Biostatistics Expert speaks at International Conference
-
June 23, 2005 ICTI Increase Drug Study Management Efficiency
-
May 9, 2005 PDMS Awards Major Pharmaceuticals Manufacturing System Contract to SSI
-
May 5, 2005 ICTI Announce Successful Implementation of a SAN
-
April 21, 2005 ICTI Marks Milestone for EDC
-
March 9, 2005 ICTI Acquires Leading EDC Software
-
March 4, 2005 CSS Albachem Secures a Share of £3.7 million R&D Programme
-
December 21, 2004 Chiral Consortium
-
December 7, 2004 CSS Enters Chiral Market Through Collaborations with ChiralQuest and IEP
-
December 7, 2004 CSS Expands Capability in Specialist Manufacturing
-
October 28, 2004 CSS Launches Unique Consortium at CPhI
-
August 23, 2004 Company Name Change
-
May 10, 2004 CSS Acquires Controlling Interest in Peptide Company ALBACHEM
-
December 2, 2003 Almac Sciences acquire PDMS
-
September 1, 2003 Senator GEORGE MITCHELL Officially Opens New CSS Facility